| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.CELL.2013.11.042 |
| P8608 | Fatcat ID | release_mz3z27ze6zhqld4gqvhs4xtojq |
| P932 | PMC publication ID | 3909465 |
| P698 | PubMed publication ID | 24439373 |
| P5875 | ResearchGate publication ID | 259806154 |
| P50 | author | Sebastian Zeissig | Q62033493 |
| P2093 | author name string | Xi Lu | |
| Sungwhan F Oh | |||
| Dennis L Kasper | |||
| Fikri Y Avci | |||
| Richard S Blumberg | |||
| Joana F Neves | |||
| Deniz Erturk-Hasdemir | |||
| Torsten Olszak | |||
| Dingding An | |||
| P2860 | cites work | Occurrence of free ceramides in Bacteroides fragilis NCTC 9343 | Q66926064 |
| Sphingolipid composition in Bacteroides species | Q80056866 | ||
| Human gut microbiome viewed across age and geography | Q24602950 | ||
| Microbial exposure during early life has persistent effects on natural killer T cell function | Q24604308 | ||
| Hay fever, hygiene, and household size | Q24674856 | ||
| Host-bacterial mutualism in the human intestine | Q27861037 | ||
| Production of α-galactosylceramide by a prominent member of the human gut microbiota | Q28534671 | ||
| Ecological and evolutionary forces shaping microbial diversity in the human intestine | Q29547586 | ||
| A microbial symbiosis factor prevents intestinal inflammatory disease | Q29614263 | ||
| An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system | Q29614267 | ||
| Succession of microbial consortia in the developing infant gut microbiome | Q29615811 | ||
| The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota | Q29619977 | ||
| Membrane sphingolipids as essential molecular signals for Bacteroides survival in the intestine | Q30499062 | ||
| Analysis of a capsular polysaccharide biosynthesis locus of Bacteroides fragilis | Q33877013 | ||
| Protein database searches using compositionally adjusted substitution matrices | Q34293765 | ||
| Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis. | Q34321127 | ||
| Longitudinal analysis of the prevalence, maintenance, and IgA response to species of the order Bacteroidales in the human gut | Q34931837 | ||
| The microbiome in infectious disease and inflammation | Q35591962 | ||
| Invariant natural killer T cells recognize lipid self antigen induced by microbial danger signals | Q35622939 | ||
| Toward an understanding of NKT cell biology: progress and paradoxes | Q36072480 | ||
| Intestinal microbes affect phenotypes and functions of invariant natural killer T cells in mice | Q36113612 | ||
| An invariant T cell receptor alpha chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4-8- T cells in mice and humans. | Q36363643 | ||
| Oxazolone colitis: A murine model of T helper cell type 2 colitis treatable with antibodies to interleukin 4. | Q36401302 | ||
| CD1d-restricted iNKT cells, the 'Swiss-Army knife' of the immune system | Q36898124 | ||
| Recognition of CD1d-restricted antigens by natural killer T cells | Q37088000 | ||
| Immunopathogenesis of psoriasis: focus on natural killer T cells. | Q37488601 | ||
| Antigen Presentation by CD1 Lipids, T Cells, and NKT Cells in Microbial Immunity | Q37499317 | ||
| Natural killer T cells and the regulation of asthma | Q37545341 | ||
| Natural killer T cells and atherosclerosis: form and function meet pathogenesis | Q37726701 | ||
| Host-bacterial symbiosis in health and disease | Q37805002 | ||
| Structural, mechanistic and regulatory studies of serine palmitoyltransferase | Q38012195 | ||
| Diverse TCRs recognize murine CD1. | Q40981487 | ||
| Obesity - extending the hygiene hypothesis | Q43285249 | ||
| Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells | Q44217456 | ||
| Recognition of bacterial glycosphingolipids by natural killer T cells | Q44582192 | ||
| Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections | Q50092191 | ||
| P433 | issue | 1-2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | sphingolipids | Q410395 |
| P304 | page(s) | 123-133 | |
| P577 | publication date | 2014-01-01 | |
| P1433 | published in | Cell | Q655814 |
| P1476 | title | Sphingolipids from a symbiotic microbe regulate homeostasis of host intestinal natural killer T cells | |
| P478 | volume | 156 |
| Q98623678 | A newly isolated strain of Halomonas sp. (HA1) exerts anticancer potential via induction of apoptosis and G2/M arrest in hepatocellular carcinoma (HepG2) cell line |
| Q34181822 | A systematic analysis of biosynthetic gene clusters in the human microbiome reveals a common family of antibiotics. |
| Q34218428 | Activation of iNKT cells by a distinct constituent of the endogenous glucosylceramide fraction |
| Q38908501 | Activation strategies for invariant natural killer T cells |
| Q47729869 | Adaptive Immune Education by Gut Microbiota Antigens. |
| Q35631737 | An integrative view of microbiome-host interactions in inflammatory bowel diseases |
| Q34425509 | Anatomical localization of commensal bacteria in immune cell homeostasis and disease |
| Q27011275 | Animals in a bacterial world: opportunities for chemical ecology |
| Q41987403 | Antibiotics and specialized metabolites from the human microbiota |
| Q37641944 | Antibiotics, birth mode, and diet shape microbiome maturation during early life. |
| Q37102522 | Bacterial lipids activate, synergize, and inhibit a developmental switch in choanoflagellates |
| Q90468698 | Bacteriophages: Uncharacterized and Dynamic Regulators of the Immune System |
| Q35148271 | Bacteriophages: an underestimated role in human and animal health? |
| Q37317771 | Bacteroides are associated with GALT iNKT cell function and reduction of microbial translocation in HIV-1 infection |
| Q91884788 | Bacteroides-Derived Sphingolipids Are Critical for Maintaining Intestinal Homeostasis and Symbiosis |
| Q90219599 | Bioactive Synthetic-Bioinformatic Natural Product Cyclic Peptides Inspired by Nonribosomal Peptide Synthetase Gene Clusters from the Human Microbiome |
| Q41996396 | Biochemical Mechanisms of Pathogen Restriction by Intestinal Bacteria |
| Q52738900 | Building conventions for unconventional lymphocytes. |
| Q47820461 | CD1d-Restricted pathways in hepatocytes control local natural killer T cell homeostasis and hepatic inflammation |
| Q39230029 | CD1d-mediated activation of group 3 innate lymphoid cells drives IL-22 production |
| Q48148150 | CD1d-mediated lipid presentation by CD11c+ cells regulates intestinal homeostasis |
| Q38847198 | Carbohydrates as T-cell antigens with implications in health and disease |
| Q31169542 | Commensal microbial regulation of natural killer T cells at the frontiers of the mucosal immune system |
| Q89176398 | Communication Between the Microbiota and Mammalian Immunity |
| Q30888516 | Complete Genome Sequence of the Novel Leech Symbiont Mucinivorans hirudinis M3T. |
| Q58750358 | Complex Network of NKT Cell Subsets Controls Immune Homeostasis in Liver and Gut |
| Q90860217 | Control of CD1d-restricted antigen presentation and inflammation by sphingomyelin |
| Q26825320 | Control of intestinal homeostasis through crosstalk between natural killer T cells and the intestinal microbiota |
| Q39228603 | Correlation between early-life regulation of the immune system by microbiota and allergy development |
| Q50253775 | Correlation, consequence, and functionality in microbiome-immune interplay |
| Q38600883 | Deciphering interactions between the gut microbiota and the immune system via microbial cultivation and minimal microbiomes. |
| Q34311731 | Deciphering the tête-à-tête between the microbiota and the immune system |
| Q26851835 | Defining dysbiosis and its influence on host immunity and disease |
| Q90862879 | Demystifying the manipulation of host immunity, metabolism, and extraintestinal tumors by the gut microbiome |
| Q34625923 | Determining microbial products and identifying molecular targets in the human microbiome |
| Q35243306 | Diet and host-microbial crosstalk in postnatal intestinal immune homeostasis |
| Q53818378 | Dietary and Microbial Oxazoles Induce Intestinal Inflammation by Modulating Aryl Hydrocarbon Receptor Responses. |
| Q38922079 | Donor-unrestricted T cells in the human CD1 system |
| Q33720577 | Early-Life Host-Microbiome Interphase: The Key Frontier for Immune Development |
| Q28076689 | Environment and Genes: What Is the Interaction? |
| Q40331504 | Exopolysaccharide from Bacillus subtilis Induces Anti-Inflammatory M2 Macrophages That Prevent T Cell-Mediated Disease |
| Q98771872 | Fecal MicroRNAs as Potential Biomarkers for Screening and Diagnosis of Intestinal Diseases |
| Q35920077 | Fostering of advanced mutualism with gut microbiota by Immunoglobulin A. |
| Q38410637 | From the Deep Sea to Everywhere: Environmental Antigens for iNKT Cells |
| Q36011511 | Gut Immunity and Type 1 Diabetes: a Mélange of Microbes, Diet, and Host Interactions? |
| Q90294140 | Gut Microbiota and Mucosal Immunity in the Neonate |
| Q57281486 | Gut Sphingolipid Composition as a Prelude to Necrotizing Enterocolitis |
| Q100694558 | Gut microbial molecules in behavioural and neurodegenerative conditions |
| Q90371831 | Gut microbiome structure and metabolic activity in inflammatory bowel disease |
| Q35170535 | Gut microbiota-generated metabolites in animal health and disease |
| Q26799980 | HUMAN MICROBIOTA. Small molecules from the human microbiota |
| Q33867430 | Helminths in the gastrointestinal tract as modulators of immunity and pathology. |
| Q36351062 | Homeostatic Immunity and the Microbiota |
| Q64910156 | Host-Microbiome Synergistic Control on Sphingolipid Metabolism by Mechanotransduction in Model Arthritis. |
| Q47912511 | Host-microbiota interplay in mediating immune disorders |
| Q28069301 | How colonization by microbiota in early life shapes the immune system |
| Q38620244 | Human Milk and Allergic Diseases: An Unsolved Puzzle. |
| Q64065204 | Immune Cell Profiling of the Cerebrospinal Fluid Provides Pathogenetic Insights Into Inflammatory Neuropathies |
| Q35755268 | Immune Responses to Intestinal Microbes in Inflammatory Bowel Diseases |
| Q26827944 | Immune-microbiota interactions in health and disease |
| Q91845019 | Immunity, microbiota and kidney disease |
| Q35747610 | In vivo imaging and tracking of host-microbiota interactions via metabolic labeling of gut anaerobic bacteria |
| Q26853123 | Inflammatory bowel disease as a model for translating the microbiome |
| Q55439901 | Influence of microbiome and diet on immune responses in food allergy models. |
| Q95320368 | Interaction between microbiota and immunity in health and disease |
| Q47552015 | Interactions between the microbiota and innate and innate-like lymphocytes. |
| Q92132680 | Intestinal Flora and Disease Mutually Shape the Regional Immune System in the Intestinal Tract |
| Q92003523 | Intestinal iNKT cells migrate to liver and contribute to hepatocyte apoptosis during alcoholic liver disease |
| Q38883497 | Invariant natural killer T cells: front line fighters in the war against pathogenic microbes |
| Q34045448 | Involvement of the iNKT cell pathway is associated with early-onset eosinophilic esophagitis and response to allergen avoidance therapy |
| Q55645985 | It Takes “Guts” to Cause Joint Inflammation: Role of Innate-Like T Cells. |
| Q35124886 | Life at the beginning: perturbation of the microbiota by antibiotics in early life and its role in health and disease |
| Q38953278 | Linking the Microbiota, Chronic Disease, and the Immune System |
| Q33831533 | Lipid metabolites as metabolic messengers in inter-organ communication |
| Q46280371 | Low-complexity microbiota in the duodenum of children with newly diagnosed ulcerative colitis |
| Q92396954 | Mapping Interactions of Microbial Metabolites with Human G-Protein-Coupled Receptors |
| Q38953250 | Mechanisms and Consequences of Antigen Presentation by CD1. |
| Q34502460 | Metagenomic cross-talk: the regulatory interplay between immunogenomics and the microbiome |
| Q74434614 | Microbes control immune cells |
| Q93088941 | Microbial genes and pathways in inflammatory bowel disease |
| Q35203778 | Microbiome manipulation modifies sex-specific risk for autoimmunity |
| Q35631728 | Microbiota and autoimmunity: exploring new avenues. |
| Q35800234 | Microbiota and host immune responses: a love-hate relationship |
| Q35541605 | Microbiota-mediated inflammation and antimicrobial defense in the intestine |
| Q36284974 | Mining the Human Gut Microbiota for Immunomodulatory Organisms |
| Q92283947 | Mining the microbiota for microbial and metabolite-based immunotherapies |
| Q35235355 | Modulation of immune development and function by intestinal microbiota. |
| Q52604165 | Modulations in the offspring gut microbiome are refractory to postnatal synbiotic supplementation among juvenile primates. |
| Q47728419 | Molecular recognition of microbial lipid-based antigens by T cells. |
| Q35539054 | Mucinivorans hirudinis gen. nov., sp. nov., an anaerobic, mucin-degrading bacterium isolated from the digestive tract of the medicinal leech Hirudo verbana |
| Q61796295 | Mucosa-associated microbiota drives pathogenic functions in IBD-derived intestinal iNKT cells |
| Q46466761 | NKT Cell-Deficient Mice Harbor an Altered Microbiota That Fuels Intestinal Inflammation during Chemically Induced Colitis. |
| Q47221129 | Natural Killer T Cells: An Ecological Evolutionary Developmental Biology Perspective |
| Q39105646 | Natural killer T cells in atherosclerosis |
| Q55383907 | Neonatal Colonic Inflammation: An Epigenetic Trigger of Adult Disease. |
| Q56533656 | Non-classical Immunity Controls Microbiota Impact on Skin Immunity and Tissue Repair |
| Q55014943 | Outgrowing the Immaturity Myth: The Cost of Defending From Neonatal Infectious Disease. |
| Q56366572 | Plasmodium and intestinal parasite perturbations of the infected host’s inflammatory responses: a systematic review |
| Q89916377 | Porphyromonas gingivalis Sphingolipid Synthesis Limits the Host Inflammatory Response |
| Q58610415 | Probiotic exopolysaccharide protects from systemic infection, inducing dual-functioning macrophages that restrict bacterial growth and limit inflammation |
| Q35907513 | Probiotics for treatment and primary prevention of allergic diseases and asthma: looking back and moving forward |
| Q26795468 | Recognition of Microbial Glycolipids by Natural Killer T Cells |
| Q34439411 | Regional specialization within the intestinal immune system |
| Q26797333 | Regulation of Lipid Specific and Vitamin Specific Non-MHC Restricted T Cells by Antigen Presenting Cells and Their Therapeutic Potentials |
| Q38527820 | Regulation of NKT Cell Localization in Homeostasis and Infection |
| Q53832051 | Risk factors and biomarkers of non-alcoholic fatty liver disease: an observational cross-sectional population survey. |
| Q64113253 | Role of Gut Microbiota in the Pharmacological Effects of Natural Products |
| Q33752553 | Role of the microbiota in immunity and inflammation |
| Q64095029 | Shaping the Gut Microbiota by Breastfeeding: The Gateway to Allergy Prevention? |
| Q53841887 | Short-term Oral Antibiotics Treatment Promotes Inflammatory Activation of Colonic Invariant Natural Killer T and Conventional CD4+ T Cells. |
| Q64146866 | Sphingolipid biosynthesis in man and microbes |
| Q38659604 | Sphingolipid metabolism potential in fecal microbiome and bronchiolitis in infants: a case-control study |
| Q28073700 | Sphingolipids as Mediators in the Crosstalk between Microbiota and Intestinal Cells: Implications for Inflammatory Bowel Disease |
| Q95327048 | Sphingolipids produced by gut bacteria enter host metabolic pathways impacting ceramide levels |
| Q90055136 | Strategies to Dissect Host-Microbial Immune Interactions That Determine Mucosal Homeostasis vs. Intestinal Inflammation in Gnotobiotic Mice |
| Q38674878 | Structural determination of lipid antigens captured at the CD1d-T-cell receptor interface |
| Q41476760 | Sulfonolipids as novel metabolite markers of Alistipes and Odoribacter affected by high-fat diets |
| Q90680930 | Supply of Methionine During Late-Pregnancy Alters Fecal Microbiota and Metabolome in Neonatal Dairy Calves Without Changes in Daily Feed Intake |
| Q37501281 | Symbiont-derived sphingolipids modulate mucosal homeostasis and B cells in teleost fish |
| Q37447311 | Synthesis of Sphingolipids Impacts Survival of Porphyromonas gingivalis and the Presentation of Surface Polysaccharides |
| Q99555096 | Systemic Immunometabolism: Challenges and Opportunities |
| Q42950291 | Talking about cross-talk: the immune system and the microbiome |
| Q37522519 | Targeting Innate-Like T Cells in Tuberculosis. |
| Q35860595 | The Alpha and Omega of Galactosylceramides in T Cell Immune Function |
| Q39270927 | The Gut Microbiome of Pediatric Crohn's Disease Patients Differs from Healthy Controls in Genes That Can Influence the Balance Between a Healthy and Dysregulated Immune Response |
| Q35893557 | The Host Shapes the Gut Microbiota via Fecal MicroRNA |
| Q98460621 | The Impact of the Microbiome on Immunity to Vaccination in Humans |
| Q28088606 | The Microbiome and Sustainable Healthcare |
| Q35866187 | The Microbiome, Systemic Immune Function, and Allotransplantation |
| Q26742170 | The Mucosal Immune System and Its Regulation by Autophagy |
| Q39077395 | The Neonatal Window of Opportunity: Setting the Stage for Life-Long Host-Microbial Interaction and Immune Homeostasis. |
| Q49961321 | The Relationship Between the Human Genome and Microbiome Comes into View |
| Q35600087 | The Response of CD1d-Restricted Invariant NKT Cells to Microbial Pathogens and Their Products |
| Q38951470 | The Role of the Microbiota in Shaping Infectious Immunity |
| Q49452437 | The Yin and Yang of Invariant Natural Killer T Cells in Tumor Immunity-Suppression of Tumor Immunity in the Intestine |
| Q97681303 | The dialogue between unconventional T cells and the microbiota |
| Q35557877 | The dynamics of the human infant gut microbiome in development and in progression toward type 1 diabetes |
| Q57463816 | The gut microbiome: Relationships with disease and opportunities for therapy |
| Q26995575 | The gut-adipose-liver axis in the metabolic syndrome |
| Q39252395 | The importance of appropriate initial bacterial colonization of the intestine in newborn, child, and adult health |
| Q92557741 | The influence of the microbiota on immune development, chronic inflammation, and cancer in the context of aging |
| Q89074520 | The interaction between invariant Natural Killer T cells and the mucosal microbiota |
| Q52715835 | The microbiome and autoimmunity: a paradigm from the gut-liver axis. |
| Q89152959 | The microbiome in autoimmune diseases |
| Q38889058 | The microbiome in early life: implications for health outcomes |
| Q38231994 | The microbiome in early life: self-completion and microbiota protection as health priorities |
| Q38757523 | The microbiota of diapause: How host-microbe associations are formed after dormancy in an aquatic crustacean |
| Q66679122 | The microbiota protects from viral-induced neurologic damage through microglia-intrinsic TLR signaling |
| Q27023425 | The regulatory role of invariant NKT cells in tumor immunity |
| Q38883507 | The role of MHC class Ib-restricted T cells during infection |
| Q59792624 | Therapeutic faecal microbiota transplantation controls intestinal inflammation through IL10 secretion by immune cells |
| Q39420607 | Therapeutic implications of bioactive sphingolipids: A focus on colorectal cancer |
| Q34493722 | Tissue-Specific Distribution of iNKT Cells Impacts Their Cytokine Response |
| Q64090873 | Tissue-resident Eomes NK cells are the major innate lymphoid cell population in human infant intestine |
| Q63362826 | Tissue-specific functions of invariant natural killer T cells |
| Q83225286 | Tissue-specific shaping of the TCR repertoire and antigen specificity of iNKT cells |
| Q38924661 | Toward revision of antimicrobial therapies in hematopoietic stem cell transplantation: target the pathogens, but protect the indigenous microbiota. |
| Q91643910 | Transcriptome Analysis of the Cecal Tonsil of Jingxing Yellow Chickens Revealed the Mechanism of Differential Resistance to Salmonella |
| Q33985473 | Transfer of gut microbiota from lean and obese mice to antibiotic-treated mice |
| Q91871894 | Transnuclear mice reveal Peyer's patch iNKT cells that regulate B-cell class switching to IgG1 |
| Q39325855 | Unusual Suspects in the Development of Obesity-Induced Inflammation and Insulin Resistance: NK cells, iNKT cells, and ILCs. |
| Q39414517 | Update on intestinal microbiota in Crohn's disease 2017: Mechanisms, Clinical application, Adverse reactions and Outlook. |
| Q89251200 | Update on the Gastrointestinal Microbiome in Systemic Sclerosis |
| Q52579441 | Urbanization and the gut microbiota in health and inflammatory bowel disease. |
| Q90860208 | What one lipid giveth, another taketh away |
| Q64945131 | Workshop Report: Modulation of Antitumor Immune Responses by Dietary and Microbial Metabolites. |
| Q38367445 | X-linked inhibitor of apoptosis protein deficiency: more than an X-linked lymphoproliferative syndrome |
| Q58586469 | iNKT Cells Suppress Pathogenic NK1.1CD8 T Cells in DSS-Induced Colitis |
| Q26801962 | iNKT and MAIT Cell Alterations in Diabetes |
| Q92074610 | α-Lactosylceramide Protects Against iNKT-Mediated Murine Airway Hyperreactivity and Liver Injury Through Competitive Inhibition of Cd1d Binding |
Search more.